- Nachrichtendetail
-
25.05.2024 12:15:47 - *DJ Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
(MORE TO FOLLOW) Dow Jones Newswires
May 25, 2024 06:15 ET (10:15 GMT)
May 25, 2024 06:15 ET (10:15 GMT)
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
NOVARTIS NAM. SF 0,49 | 904278 | Hamburg | 0,000 | 25.06.24 01:15:57 | ±0,000 | ±0,00% | 0,000 | 0,000 | 0,000 | 80,190 |
|
NOVARTIS NAM. ADR 1 | 907122 | Frankfurt | 96,400 | 24.06.24 08:16:11 | -0,600 | -0,62% | 0,000 | 0,000 | 96,400 | 97,000 |
